Olema Pharmaceuticals Grants Stock Options to New Employees Under 2022 Inducement Plan
Reuters
Oct 03
Olema Pharmaceuticals Grants Stock Options to New Employees Under 2022 Inducement Plan
Olema Pharmaceuticals Inc. has granted stock options to three new employees, allowing them to purchase a total of 77,000 shares of the company's common stock. The options have an exercise price of $11.04 per share, matching the closing price on October 1, 2025. The options will vest over four years, with 25 percent becoming available after the first year and the remainder vesting in equal monthly installments over the following three years. The stock options have a 10-year term and are granted under Olema's 2022 Inducement Plan.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9539260-en) on October 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.